TRILACICLIB for Small cell lung cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 20 adverse event reports in the FDA FAERS database where TRILACICLIB was used for Small cell lung cancer.

Most Reported Side Effects for TRILACICLIB

Side Effect	Reports	%	Deaths	Hosp.
Off label use	25	11.1%	0	1
Myelosuppression	24	10.6%	2	20
Dyspnoea	18	8.0%	1	13
Pneumonia	18	8.0%	4	17
White blood cell count decreased	18	8.0%	1	14
Platelet count decreased	17	7.5%	1	16
Anaemia	15	6.6%	2	15
Performance status decreased	14	6.2%	0	14
Death	13	5.8%	13	1
Infection	12	5.3%	0	11
Haemorrhage	11	4.9%	0	11
Red blood cell count decreased	11	4.9%	0	10
Sepsis	11	4.9%	1	11
Chest discomfort	10	4.4%	0	9
Cough	10	4.4%	1	9